Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas
about
Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapyA novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biologyBoning up on autophagy: the role of autophagy in skeletal biologyThe role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.Unveiling the molecular pathogenesis of chordoma: a new paradigm for molecular targeting of rare cancers.Systemic therapy options for unresectable and metastatic chordomas.Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review.Frequent activation of EGFR in advanced chordomas.Phase II study on lapatinib in advanced EGFR-positive chordoma.Integrated miRNA-mRNA analysis revealing the potential roles of miRNAs in chordomas.Multidisciplinary management of recurrent chordomas.Erlotinib inhibits growth of a patient-derived chordoma xenograft.Generation of a patient-derived chordoma xenograft and characterization of the phosphoproteome in a recurrent chordoma.Development of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies.PD-1, PD-L1, PD-L2 expression in the chordoma microenvironmentNovel targeted therapies in chordoma: an update.Chordoma: an update on the pathophysiology and molecular mechanismsMultidisciplinary approach of lumbo-sacral chordoma: From oncological treatment to reconstructive surgery.EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFRGenetic aberrations and molecular biology of skull base chordoma and chondrosarcoma.Platelet-derived growth factor receptor beta: a novel urinary biomarker for recurrence of non-muscle-invasive bladder cancer.Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma.Profiling of phospho-AKT, phospho-mTOR, phospho-MAPK and EGFR in non-small cell lung cancer.ErbB receptors as prognostic and therapeutic drug targets in bone and soft tissue sarcomas.Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.The driver landscape of sporadic chordomaMicroRNA profiling and bioinformatics analyses reveal the potential roles of microRNAs in chordoma.Comprehensive analysis of mRNA-lncRNA co-expression profile revealing crucial role of imprinted gene cluster DLK1-MEG3 in chordoma.Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib.
P2860
Q21560915-7374D056-BDD6-41F8-A608-D0C2E93A3F50Q28534867-7198D85F-FC8F-4FBC-8E3B-1222E30AF74EQ28659840-1A84E1A7-7D92-4889-9BEF-0E7DF3DA1C02Q33274011-8D0E6F75-A6AA-4ABD-8CF6-DAA65D3C91EFQ33274088-3C25563B-49B8-4EF1-8704-E9BD82FD8EDBQ33274146-4F47BD73-2006-4411-8D32-D7C2834907FCQ33274256-ABF8AF9B-1494-4FE1-BC41-12ECA97EB4EAQ33274473-A38641A6-9EAC-47E7-8A9F-9D457CF062ACQ33274760-D5D1235A-7725-41F5-8029-A26C037D19AFQ33274852-85AB41CD-AB59-4865-A05D-BA5D18114C98Q33274875-517D212D-B20A-4C62-8EC9-F0B0EDC05B00Q33275026-10FE44D5-D020-4878-B953-E11A7BB8D62BQ33275031-D611C969-9708-44FF-9E10-50A264F917DFQ33275064-64FCE42A-EFA1-4D2E-856E-160E8BA35B9BQ33275412-AFB38569-B326-4A0C-B6CC-2489FBF59D17Q33275653-EC2C57B9-F378-42A0-9E98-95DB3391377EQ33275783-788F51AA-3B83-457D-847D-A8B74E2CA917Q33275786-63256CB9-D505-49B3-8A93-9FBF742E68ACQ33276007-7F3F4DD1-A19C-442F-AD64-6AFDCD1552A0Q33276057-DDE1E6D9-C16F-45BB-A45D-ECF010CC7E36Q33276468-3E964207-90BD-4A49-A79E-F59678CB92D7Q33573393-ADD13D43-4A83-4490-9CF8-4485A818E29BQ34633416-4B0E4B39-C5FB-49F7-9C7D-45A1CBC83259Q37733727-828F07A6-F9B5-4CBA-9FCF-FA096B8412ECQ38263000-FA86243D-15A8-4552-A632-972145E7C362Q38591828-02C956BD-5653-4E8D-9477-07BA9E969A70Q38611099-ADABB2F1-2603-4FCD-AEA6-52A30ECCE7D9Q42376040-05439B2D-358E-451F-BCA0-0CE428CB3309Q47135813-9D6AF5C9-2B5A-4464-831F-DDA4B5A89722Q49325078-300CDCA3-D4C2-49ED-96B6-5216732A7B12Q54628923-8FEEE0A1-F1CF-4734-B9DB-D350F94B82FE
P2860
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas
@ast
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas
@en
Analysis of receptor tyrosine kinases
@nl
type
label
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas
@ast
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas
@en
Analysis of receptor tyrosine kinases
@nl
prefLabel
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas
@ast
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas
@en
Analysis of receptor tyrosine kinases
@nl
P2093
P2860
P50
P356
P1433
P1476
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas
@en
P2093
Elena Conca
Emanuela Virdis
Marta Orsenigo
P2860
P304
P356
10.1093/NEUONC/NOQ003
P50
P577
2010-02-17T00:00:00Z